Graubündner Kantonalbank

Swiss Cantons Basel-City and Zurich pioneer the settlement of digital bonds transactions in SNB's Swiss-Franc wCBDC on SIX Digital Exchange

Retrieved on: 
Monday, December 4, 2023
SIX Swiss Exchange, Graubündner Kantonalbank, Swiss National Bank, History, National Securities Depository Limited, Blockchain, DLT, SNB, DTI, Basler Kantonalbank, ISIN, SIX, SDX, CHF, Cryptocurrency

ZURICH, Dec. 4, 2023 /PRNewswire/ -- On 1 December 2023, digital bond issuances by the Cantons of Basel-City and Zurich were successfully settled using real CHF wholesale central bank digital currency (wCBDC) issued by the Swiss National Bank (SNB) on SIX Digital Exchange (SDX).

Key Points: 
  • ZURICH, Dec. 4, 2023 /PRNewswire/ -- On 1 December 2023, digital bond issuances by the Cantons of Basel-City and Zurich were successfully settled using real CHF wholesale central bank digital currency (wCBDC) issued by the Swiss National Bank (SNB) on SIX Digital Exchange (SDX).
  • It is the first time the SNB has issued real wCBDC in Swiss francs on a financial market infrastructure based on distributed ledger technology (DLT).
  • As part of the project, Basler Kantonalbank and Zürcher Kantonalbank, acted as issuer agents of the cantons of Basel -City and Zurich .
  • In addition, as dual-listed bonds, they will be listed and tradeable at SDX (exchange) and SIX Swiss Exchange.

Bellevue Asset Management AG: Emerging Markets Healthcare sector comeback

Retrieved on: 
Wednesday, February 22, 2023
Pharmacy, Government, Lecanemab, Private Asset Management, Graubündner Kantonalbank, Daiichi Sankyo, Investment, Zanubrutinib, Breast cancer, WuXi Biologics, Patient, Cardiology, Business administration, Hip, Biogen, Zurich University of Applied Sciences/ZHAW, Policy, Health care, BeiGene, Growth, Health, Applied science, COVID, Multiple myeloma, BTK, Apollo Hospitals, AstraZeneca, Elective surgery, Cancer, Zurich University, Sun Pharma, Pharmaceutical industry

After a string of difficult years, a trend reversal is under way in emerging market healthcare stocks.

Key Points: 
  • After a string of difficult years, a trend reversal is under way in emerging market healthcare stocks.
  • In the Bellevue Emerging Markets Healthcare Fund, the China allocation is more than 60% and in the Bellevue Asia Pacific Healthcare Fund it is about 40%.
  • Remo Krauer has been a Senior Portfolio Manager Healthcare Funds & Mandates at Bellevue Asset Management since 2018.
  • Previously, he worked at Zürcher Kantonalbank, first as Senior Portfolio Manager, then as Head Portfolio Construction for Private Asset Management.

TWINT and Cembra’s subsidiary Swissbilling agree on partnership

Retrieved on: 
Friday, September 23, 2022
Cembra, Smartphone, BCV, Graubündner Kantonalbank, Banque cantonale vaudoise, TWINT, Bloomberg, SIX Swiss Exchange, Credit Suisse, Solution, Friends, Lmg-Pist 41/44, Insurance, Supermarket, SIX, UBS, Online shopping, MSCI

Zurich TWINT, the leading Swiss payment app, and Swissbilling, the Cembra subsidiary specialised in pay by invoice and billing solutions, have laid the foundation for a collaboration.

Key Points: 
  • Zurich TWINT, the leading Swiss payment app, and Swissbilling, the Cembra subsidiary specialised in pay by invoice and billing solutions, have laid the foundation for a collaboration.
  • The Swiss payment app TWINT simplifies the lives of over 4 million users every day and has become an indispensable payment method in Switzerland.
  • Through a collaboration with Swissbilling, Cembra's subsidiary specialised in pay by invoice and billing solutions, TWINTs payment options will be expanded and made more customisable.
  • The launch of the digitally integrated payment solution from TWINT and Swissbilling is planned for summer 2023.

Bellevue Asset Management AG: Asia’s rapidly expanding healthcare market

Retrieved on: 
Thursday, August 18, 2022
EPS, Risk, CFA, SIX Swiss Exchange, AG, Research, Prospectus, Patient, Investment, Eyebrow, Multiple myeloma, Lymphatic system, Federal Executive Boards, Board of directors, Technology, Policy, Graubündner Kantonalbank, Post office box, Zurich University, PEG, Public policy, House, Medtech, CHF, Growth, ISIN, COVID, Zurich University of Applied Sciences/ZHAW, Olympus, CNMV, Judgement, Takeda, Lux, Annual report, Association, Health care, SICAV, Johnson & Johnson, Capital, Government, TEL, Daiichi Sankyo, Applied science, Security (finance), Healthcare, Pharmaceutical industry, Fine chemical

Oliver Kubli, Portfolio Manager, Bellevue Asia Pacific Healthcare Fund, Bellevue Asset Management

Key Points: 
  • Oliver Kubli, Portfolio Manager, Bellevue Asia Pacific Healthcare Fund, Bellevue Asset Management
    The healthcare market in emerging Asian economies is a giant growth market.
  • Emerging Asian countries have been particularly active in pursuing sweeping healthcare reforms, in order to keep up with exploding demand.
  • Despite the occasionally brutal stock market sell-offs, Chinese healthcare stocks have outperformed the US stock market by more than 1 000 percent over the past 18 years.
  • About 40% of the Bellevue Asia Pacific Healthcare Fund (ISIN B-USD LU1587984847) is currently invested in China.

MEDIMAPS GROUP Raises $20 Million to Expand and to Commercialize AI Product Portfolio for Bone Health Assessment Utilizing Routine Medical Images

Retrieved on: 
Wednesday, December 1, 2021
Radiology, Software, Networks, Finance, Medical Devices, Internet, Hardware, Hospitals, Data Management, Professional Services, Technology, Practice Management, Managed Care, Medical Supplies, General Health, Biotechnology, Surgery, Health, Fracture, UBS, Pelvic fracture, International Osteoporosis Foundation, Graubündner Kantonalbank, Physician, Risk, Disability, Journal, BMD, TBS, Pharmacology, Swisscom, Osteoporosis, IMPACT, American Society for Bone and Mineral Research, Gold, Bone density, Workflow, Investment, USA, Johnelle Hunt, Osteo-odonto-keratoprosthesis, Radiation, ICT, A.I, Solution, Osteopenia, Investor, Credit Suisse, Multimedia, Intelligence, Patient, Ageing, Technology, Trabecular bone score, Prevalence, Communication, Health, New Entrepreneurs Foundation, Bone fracture, Renewable energy, Medical imaging, Financial services, Silviculture

The funds raised will be used to expand its product portfolio with the development and market launch of its patented A.I.

Key Points: 
  • The funds raised will be used to expand its product portfolio with the development and market launch of its patented A.I.
  • The companys current flagship product, Trabecular Bone Score (TBS iNsight), has received medical reimbursement in the U.S. beginning January 1, 2022.
  • Of the patients receiving a bone mineral density (BMD) assessment, roughly 40% are incompletely diagnosed, because BMD5 can only measure quantity of bone, not quality of bone.
  • Medimaps is positioned well to lead the way for innovative solutions for bone health assessment and advancing A.I.